Learn how CRS and ICANS present in patients undergoing immunotherapy and what clinicians should know about recognizing and managing these toxicities.
Turab Mohammed, MD
Advertisement
Turab Mohammed, MD, is a hematology and oncology specialist at Novant Health in Wilmington, NC.
Articles by Turab Mohammed, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
ATTR-CM Incidence, Prevalence Rose Sharply in the US
4
Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS
5